India focusing on procuring oxygen-related equipment: Shringla

India is looking at getting around 550 oxygen generating plants, 4,000 oxygen concentrators and 10,000 oxygen cylinders from abroad: Foreign Secretary Harsh Vardhan Shringla

India's High Commissioner to Bangladesh, Harsh Vardhan Shringla.  Photo: ANI Twitter Handle
File photo: Harsh Vardhan Shringla
Press Trust of India New Delhi
1 min read Last Updated : Apr 29 2021 | 2:34 PM IST

India is looking at getting around 550 oxygen generating plants, 4,000 oxygen concentrators and 10,000 oxygen cylinders from abroad to deal with the coronavirus pandemic, Foreign Secretary Harsh Vardhan Shringla said on Thursday.

Shringla also said that India is looking at procuring 400,000 units of Remdesivir medicine from Egypt besides exploring to get it from countries like the United Arab Emirates, Bangladesh and Uzbekistan.

At a media media briefing, he said over 40 countries have come forward to offer assistance to India to help in view of the unprecedented situation.

The foreign secretary said the government has been majorly focusing on procuring oxygen generators, concentrators, oxygen cylinders, cryogenic tankers as well as liquid oxygen.

He said the medical supplies are being sourced through direct procurement and other modes.

Shringla said two special aircraft carrying large amounts of medical supplies from the US are expected to reach India by Friday and another one is likely in the next few days.

As India battles a devastating second wave of coronavirus pandemic, countries around the world have announced sending medical supplies to help it tide over the situation.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Apr 29 2021 | 2:32 PM IST

Next Story